Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vertex Pharmaceuticals Incorporated

Clinical trials sponsored by Vertex Pharmaceuticals Incorporated, explained in plain language.

Vertex Pharmaceuticals Incorporated VRTX NASDAQ

Biopharmaceutical company focused on cystic fibrosis and other serious diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 15 Not yet finished but already full! 17 Completed 18 Terminated 1

Experimental pill for rare lung and liver disease hits snag: trial stopped early

Disease control Terminated

This study tested an experimental drug called VX-864 in 14 people with a severe form of alpha-1 antitrypsin deficiency (PiZZ genotype). The goal was to see if the pill could raise protective protein levels in the blood and reduce harmful buildup in the liver. The trial was termin…

Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control

Last updated Jun 26, 2026 15:04 UTC